CAS RN: 86340-94-5
N-Iodosaccharin
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
98%(T) (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20251124
250mg / 1g / 5g
Confirm by inquiry
Shanghai, Shandong Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥98%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 86340-94-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥98%
0
Out of Stock
Shenzhen
Inquiry
86340-94-5 / 2-iodo-1,1-dioxo-1,2-benzothiazol-3-one
Standard CAS: 86340-94-5
Multi CAS: No
Basic Information
copy
CAS
86340-94-5 copy
Multi CAS
No copy
Molecular Formula
C7H4InO3S copy
Molecular Weight
309.080000 copy
Exact Mass
308.895660 copy
InChI
InChI=1S/C7H4INO3S/c8-9-7(10)5-3-1-2-4-6(5)13(9,11)12/h1-4H copy
InChIKey
XQKQROJYWLWDMP-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Aromatic heavy atom count
6 copy
H-bond acceptors
3 copy
Molar refractivity
53.82 copy
TPSA
54.45 copy
LogP / Solubility
WLOGP
1.18 copy
MLOGP
1.05 copy
XLogP3
1.3 copy
Consensus LogP
1.18 copy
Log S (ESOL)
-2.84 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.95 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.65 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.77 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy